Bioactive Bone Substitute in a Rabbit Ulna Model: Preclinical Study

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Surgery

Background:

• Current treatments for long-bone defects and significant bone loss have limitations.
• Advanced technologies are needed to create effective bone regeneration solutions.
• This study introduces a novel bioactive bone substitute designed for enhanced bone repair.

Purpose of the Study:

• To develop and evaluate a novel bioactive bone substitute for bone regeneration.
• To assess the safety and efficacy of the bone substitute in a preclinical model.
• To leverage 3D patterning, controlled growth factor release, and conjugation for clinical bone repair.

Main Methods:

• A 3D patterned cylindrical scaffold (1.5 cm length, 5 mm diameter) was fabricated using poly(L-lactic acid) (PLLA).
• Bone morphogenetic protein 2 (BMP2) was conjugated to the scaffold using alginate catechol and collagen for sustained release.
• In vitro and in vivo evaluations included physico-chemical properties, biocompatibility, histological analysis, and radiography (X-ray, CT, micro-CT) in a rabbit ulna model.

Main Results:

• The bone substitute (BS) exhibited suitable mechanical properties (80±10 MPa compression strength) and a design conducive to clinical handling.
• Sustained BMP2 release was observed for two months.
• Histological analysis confirmed good biocompatibility with minimal inflammation, and radiographic assessments showed effective new bone formation in the rabbit ulna defect model.

Conclusions:

• The novel bioactive bone substitute demonstrates promising preclinical safety and efficacy.
• The combination of 3D patterning and controlled BMP2 release facilitates bone regeneration.
• This engineered bone substitute holds potential for clinical application in treating bone defects and tissue loss.